These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18768783)

  • 61. Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.
    Carlsson B; Hou M; Giandomenico V; Nilsson B; Totterman TH; Essand M
    J Infect Dis; 2005 Dec; 192(11):1912-20. PubMed ID: 16267762
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.
    Poiret T; Axelsson-Robertson R; Remberger M; Luo XH; Rao M; Nagchowdhury A; Von Landenberg A; Ernberg I; Ringden O; Maeurer M
    Front Immunol; 2018; 9():760. PubMed ID: 29692783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [T cell receptor β-chain CDR3 spectratyping and cytomegalovirus activation in allogeneic hematopoietic stem cell transplant recipients].
    Wu Z; Jing M; Liang H; Yang R; Huang Y; Chen X; Hu J; Fan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(5):515-521. PubMed ID: 28087912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.
    Smith C; Brennan RM; Tey SK; Smyth MJ; Burrows SR; Miles JJ; Hill GR; Khanna R
    J Virol; 2016 Aug; 90(16):7497-507. PubMed ID: 27279616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation.
    Kato T; Nishida T; Ito Y; Murase M; Murata M; Naoe T
    Cell Immunol; 2014; 288(1-2):53-9. PubMed ID: 24657340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
    N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles.
    Kondo E; Akatsuka Y; Kuzushima K; Tsujimura K; Asakura S; Tajima K; Kagami Y; Kodera Y; Tanimoto M; Morishima Y; Takahashi T
    Blood; 2004 Jan; 103(2):630-8. PubMed ID: 12947002
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs.
    Ruan GP; Ma L; Wen Q; Luo W; Zhou MQ; Wang XN
    Cell Mol Immunol; 2008 Jun; 5(3):197-201. PubMed ID: 18582401
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.
    Sundarasetty BS; Kloess S; Oberschmidt O; Naundorf S; Kuehlcke K; Daenthanasanmak A; Gerasch L; Figueiredo C; Blasczyk R; Ruggiero E; Fronza R; Schmidt M; von Kalle C; Rothe M; Ganser A; Koehl U; Stripecke R
    J Transl Med; 2015 Jul; 13():240. PubMed ID: 26198406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.
    Szmania S; Galloway A; Bruorton M; Musk P; Aubert G; Arthur A; Pyle H; Hensel N; Ta N; Lamb L; Dodi T; Madrigal A; Barrett J; Henslee-Downey J; van Rhee F
    Blood; 2001 Aug; 98(3):505-12. PubMed ID: 11468143
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
    Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D
    J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation.
    Salguero G; Daenthanasanmak A; Münz C; Raykova A; Guzmán CA; Riese P; Figueiredo C; Länger F; Schneider A; Macke L; Sundarasetty BS; Witte T; Ganser A; Stripecke R
    J Immunol; 2014 May; 192(10):4636-47. PubMed ID: 24740501
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
    Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
    J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantation.
    Jiang Z; Fan Z; Zhang T; Lin R; Xu H; Xu N; Huang F; Chi P; Ou X; Wang Z; Liu H; Zhao K; Jiang L; Yu S; Sun J; Liu Q; Xuan L
    Br J Haematol; 2024 Apr; 204(4):1393-1401. PubMed ID: 38168845
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cytomegalovirus specific cytotoxic T lymphocytes for treatment of refractory cytomegalovirus infection in patients following allogeneic hematopoietic stem cell transplantation].
    Xu Z; Huang X; Sun Y; Wang F; Yan C; Zhang X; Han W; Chen Y; Wang J; Chen H; Wang Y; Zhang Y; Liu K; Xu L
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):101-5. PubMed ID: 25907838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus.
    Pei XY; Zhao XY; Chang YJ; Liu J; Xu LP; Wang Y; Zhang XH; Han W; Chen YH; Huang XJ
    J Infect Dis; 2017 Nov; 216(8):945-956. PubMed ID: 29029297
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CMV-specific immune reconstitution following allogeneic stem cell transplantation.
    Blyth E; Withers B; Clancy L; Gottlieb D
    Virulence; 2016 Nov; 7(8):967-980. PubMed ID: 27580355
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
    Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
    Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
    Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
    Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.